Published in Semin Hematol on April 01, 2000
Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone (2004) 1.57
The wrickkened pathways of FGF23, MEPE and PHEX. Crit Rev Oral Biol Med (2004) 1.28
Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population. Indian J Med Res (2013) 1.21
Transfusion in the age of molecular diagnostics. Hematology Am Soc Hematol Educ Program (2009) 1.03
Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration. Neurobiol Dis (2012) 0.99
An easy and efficient strategy for KEL genotyping in a multiethnic population. Rev Bras Hematol Hemoter (2013) 0.92
Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia. J Biomed Biotechnol (2010) 0.84
Spontaneously arising red cells with a McLeod-like phenotype in normal donors. Mutat Res (2009) 0.81
Ablation of the Kell/Xk complex alters erythrocyte divalent cation homeostasis. Blood Cells Mol Dis (2012) 0.80
The effect of a novel intergenic polymorphism (rs11774572) on HDL-cholesterol concentrations depends on TaqIB polymorphism in the cholesterol ester transfer protein gene. Nutr Metab Cardiovasc Dis (2009) 0.79
Molecular Basis of KELnull Phenotype in Brazilians. Transfus Med Hemother (2014) 0.79
Two McLeod patients with novel mutations in XK. J Neurol Sci (2011) 0.78
Another example of a KEL1 variant red cell phenotype due to a threonine to serine change at position 193 of Kell glycoprotein. Transfusion (2008) 0.77
Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI. Transfusion (2013) 0.77
Clinical Significance of an Alloantibody against the Kell Blood Group Glycoprotein. Transfus Med Hemother (2016) 0.75
Distribution of Kell phenotype among pregnant women in Sokoto, North Western Nigeria. Pan Afr Med J (2015) 0.75
Vectorial discharge of peptides released by puromycin from attached ribosomes. Proc Natl Acad Sci U S A (1966) 5.69
Synthesis and transfer of amylase in pigeon pancreatic micromosomes. J Biol Chem (1966) 5.28
Biosynthesis of serum proteins and ferritin by free and attached ribosomes of rat liver. J Biol Chem (1969) 3.66
Colchicine inhibition of plasma protein release from rat hepatocytes. J Cell Biol (1975) 2.56
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet (2000) 2.31
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab (2007) 1.93
Studies on the transfer of incomplete polypeptide chains across rat liver microsomal membranes in vitro. J Biol Chem (1967) 1.90
The synthesis of serum proteins on attached rather than free ribosomes of rat liver. Biochem Biophys Res Commun (1968) 1.83
The distribution of radioactive peptides synthesized by polysomes and ribosomal subunits combined in vitro with microsomal membranes. Biochim Biophys Acta (1973) 1.82
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia. Blood (1998) 1.71
The secretory pathways of rat serum glycoproteins and albumin. Localization of newly formed proteins within the endoplasmic reticulum. J Cell Biol (1972) 1.60
Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood (1996) 1.59
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol (1999) 1.51
Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Ann Oncol (1995) 1.49
Thyrotropin receptor mutations and thyroid hyperfunctioning adenomas ten years after their first discovery: unresolved questions. Thyroid (2003) 1.46
Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon. Italian Cooperative Study Group on Chronic Myeloid Leukaemia. Br J Haematol (2000) 1.46
The intracellular pathway of newly formed rat liver catalase. Arch Biochem Biophys (1972) 1.41
Heat-induced unfolding of neocarzinostatin, a small all-beta protein investigated by small-angle X-ray scattering. J Mol Biol (2001) 1.41
Antiproteinuric effect of Losartan in patients with chronic renal diseases. Nephrol Dial Transplant (1997) 1.41
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia. Haematologica (1999) 1.39
Retracted Secretion of biologically active recombinant fibrinogen by yeast. J Biol Chem (1995) 1.39
An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science (1990) 1.21
The in vivo effect of colchicine on the addition of galactose and sialic acid to rat hepatic serum glycoproteins. J Biol Chem (1976) 1.20
Bortezomib as an antitumor agent. Curr Pharm Biotechnol (2006) 1.17
Intracellular disposition of H3-morphine in the brain and liver of nontolerant and tolerant guinea pigs. J Pharmacol Exp Ther (1967) 1.17
Localization of the McLeod locus (XK) within Xp21 by deletion analysis. Am J Hum Genet (1988) 1.16
Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J Clin Endocrinol Metab (2000) 1.15
Patient-controlled analgesia in children and adolescents: a randomized, prospective comparison with intramuscular administration of morphine for postoperative analgesia. J Pediatr (1991) 1.15
Staging and prognosis in chronic myelogenous leukemia. Semin Hematol (1988) 1.15
Proteolipid involvement in human erythrocyte membrane function. Biochim Biophys Acta (1972) 1.15
Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. Proc Natl Acad Sci U S A (1991) 1.15
Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci U S A (1991) 1.14
Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab (1997) 1.13
Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood (1999) 1.10
Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol (1989) 1.10
Rituximab for myasthenia gravis developing after bone marrow transplant. Neurology (2000) 1.10
In vivo effect of colchicine on hepatic protein synthesis and on the conversion of proalbumin to serum albumin. J Cell Biol (1978) 1.09
Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab (1998) 1.08
The psychosocial impact of multiple sclerosis: exploring the patient's perspective. Health Psychol (1999) 1.05
Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid (2002) 1.04
Kell blood group antigens are part of a 93,000-dalton red cell membrane protein. J Biol Chem (1986) 1.03
Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors. Eur J Endocrinol (2001) 1.03
Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues. J Endocrinol Invest (2004) 0.98
Graves' disease, thyroid nodules and thyroid cancer. Clin Endocrinol (Oxf) (2001) 0.98
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia. Clin Infect Dis (2001) 0.97
Notch signaling is involved in expression of thyrocyte differentiation markers and is down-regulated in thyroid tumors. J Clin Endocrinol Metab (2008) 0.97
Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J Exp Med (2000) 0.96
Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis. Mult Scler (1999) 0.95
Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. J Clin Invest (1991) 0.94
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. Pharmacogenomics J (2012) 0.94
Photodynamic therapy of ascites tumours within the peritoneal cavity. Br J Cancer (1986) 0.94
Elevated serum creatine phosphokinase in subjects with McLeod syndrome. Vox Sang (1981) 0.94
Investigation of the presence of ghrelin in the central nervous system of the rat and mouse. Neuroscience (2011) 0.93
Biosynthesis of dog fibrinogen. Characterization of nascent fibrinogen in the rough endoplasmic reticulum. Eur J Biochem (1982) 0.93
Localization of enzymes involved in polyphosphoinositids metabolism on the cytoplasmic surface of the human erythrocyte membrane. Biochim Biophys Acta (1975) 0.93
Molecular defects underlying the Kell null phenotype. J Biol Chem (2001) 0.93
Intracellular assembly of human fibrinogen. J Biol Chem (1983) 0.93
Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis. Nephron (1999) 0.92
The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells. Blood (1993) 0.91
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. J Infect Dis (1994) 0.90
17beta-estradiol synthesis in the adult male rat retina. Exp Eye Res (2007) 0.90
Cellular components and tunic architecture of the solitary ascidian Styela canopus (Stolidobranchiata, Styelidae). Tissue Cell (1998) 0.90
Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. J Biol Chem (1994) 0.89
Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J Biol Chem (1990) 0.89
Phospholipid metabolism in intact and modified erythrocyte membranes. J Cell Biol (1971) 0.89
Caveat to genotype-phenotype correlation in mucopolysaccharidosis type II: discordant clinical severity of R468W and R468Q mutations of the iduronate-2-sulfatase gene. Hum Mutat (1993) 0.89
Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain. J Am Coll Cardiol (1985) 0.89
Expression of Kell blood group protein in nonerythroid tissues. Blood (2000) 0.89
Carboxy-terminal-extended variant of the human fibrinogen alpha subunit: a novel exon conferring marked homology to beta and gamma subunits. Biochemistry (1992) 0.89
Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol (1996) 0.89
[Health-related quality of life in patients with chronic kidney disease]. G Ital Nefrol (2008) 0.88
Effects of a mixture of polychlorinated biphenyls (Aroclor 1254) on the transcriptional activity of thyroid hormone receptor. J Endocrinol Invest (2003) 0.88
Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem (1990) 0.88
Carotid endarterectomy with contralateral carotid artery occlusion: is this a higher risk subgroup? Eur J Vasc Endovasc Surg (2002) 0.88
Biosynthesis of mouse erythrocyte membrane proteins by Friend erythroleukemia cells. Biochim Biophys Acta (1981) 0.88
Tyrosine sulfation of proteins from the human hepatoma cell line HepG2. Proc Natl Acad Sci U S A (1985) 0.88
Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. Bone Marrow Transplant (2009) 0.88
Recent developments in the Kell blood group system. Transfus Med Rev (1987) 0.88
Fibrinogen precursors. Order of assembly of fibrinogen chains. J Biol Chem (1984) 0.87
Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. J Biol Chem (1991) 0.87
All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi). Haematologica (1997) 0.87
Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding. Biochem Biophys Res Commun (1990) 0.87
Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin. Cell Prolif (2009) 0.87
Diagnostic tests for choreoacanthocytosis. Neurology (1991) 0.87
Scleroembolization for treatment of hypertension caused by intrarenal arterial fibrodysplasia. Clin Nephrol (1984) 0.87
Rituximab for the treatment of type II mixed cryoglobulinemia. Haematologica (1999) 0.86
Effect of local anesthetics on plasma protein secretion by rat hepatocytes. Biochim Biophys Acta (1977) 0.86
Biosynthesis of high density lipoprotein by chicken liver: nature of nascent intracellular high density lipoprotein. J Cell Biol (1983) 0.86
The 3',5'-cyclic adenosine monophosphate response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas. Endocrinology (2000) 0.86
Iris indocyanine green videoangiography in diabetic iridopathy. Br J Ophthalmol (1996) 0.85
Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas. Eur J Endocrinol (2000) 0.85
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates. J Endocrinol Invest (2007) 0.85
Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. J Endocrinol Invest (1998) 0.85
Isolation of Kell-active protein from the red cell membrane. Transfusion (1984) 0.85
Ectopic expression of FSH receptor isoforms in neoplastic but not in endothelial cells from pancreatic neuroendocrine tumors. J Endocrinol Invest (2012) 0.85
PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells. J Cell Biochem (2008) 0.85